Over the last 20 years, Mr. Hovard has held multiple leadership roles at subsidiaries of Coloplast, a publicly-traded global medical device company. Most recently, he served as the President of Interventional Urology from 2011 to 2019. At Interventional Urology, Mr. Hovard operated in a CEO capacity leading approximately 900 employees across corporate development with complete oversight of R&D, operations/manufacturing, marketing, sales, human resources, finance and legal.
Current role